The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients

Nicholas J. Sarlis, MD, PhD, FACP

The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients

Webinars

Videos

Featuring:

Tracy Baroni-Allmon, BS Pharm, JD

Head, Global Oncology Access &
Reimbursement Policy
Takeda

Andrea Ferris, MBA

President and Chief Executive Officer
LUNGevity Foundation

Ryan Hohma, JD

Vice President - Public Affairs
Friends of Cancer Research

Paul Jeffrey, PharmD

Principal
Jeff℞ey Consulting
Retired, Sr. Director of Pharmacy
MassHealth

Robert Orlowski, MD, PhD

Chairman, Ad Interim, Director of Myeloma and Professor of Medicine
Department of Lymphoma/Myeloma and
Experimental Therapeutics
Division of Cancer Medicine
MD Anderson Cancer Center

Andrew Robertson, PhD, JD

VP, Head of Global Regulatory Policy and Innovation
Takeda

Nicholas J. Sarlis, MD, PhD, FACP

Head of Medical Content
Amplity Health

Live webinar occurred on June 28th, 2:00 – 3:00 pm ET.

This recording is provided by Takeda Oncology.

Designed to foster a conversation on exploring opportunities to sustain early approval and access to treatments for patients with serious and life-threatening conditions, this webinar includes the following topics:

An overview of accelerated approval and its use in oncology
The impact of the approval process on patients and physicians
A discussion of how to evolve the process to meet patients’ needs
Identification of policy action that could benefit the cancer community

The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients

Featuring:

Subscribe Today!

I'd like to receive:

Stay In The Know

The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients

Featuring:

Related Articles

Subscribe Today!

I'd like to receive:

Stay In The Know